Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Sell
14,602
-13,335
-48% -$1.61M 0.04% 259
2026
Q1
$4.57M Buy
27,937
+93
+0.3% +$14.3K 0.17% 92
2025
Q4
$4.85M Buy
27,844
+16,471
+145% +$3.01M 0.15% 105
2025
Q3
$1.64M Sell
11,373
-8,185
-42% -$1M 0.05% 230
2025
Q2
$1.97M Sell
19,558
-12,539
-39% -$959K 0.07% 189
2025
Q1
$2.45M Sell
32,097
-4,988
-13% -$382K 0.11% 148
2024
Q4
$2.56M Sell
37,085
-9,101
-20% -$655K 0.09% 151
2024
Q3
$3.37M Buy
46,186
+23,166
+101% +$1.71M 0.13% 121
2024
Q2
$1.54M Sell
23,020
-29,923
-57% -$1.16M 0.06% 227
2024
Q1
$1.44M Sell
52,943
-1,084
-2% -$30.3K 0.06% 245
2023
Q4
$1.67M Buy
54,027
+6,340
+13% +$164K 0.07% 208
2023
Q3
$1.2M Sell
47,687
-20,828
-30% -$476K 0.07% 240
2023
Q2
$1.45M Sell
68,515
-2,880
-4% -$54.6K 0.08% 222
2023
Q1
$1.22M Buy
+71,395
New +$1.39M 0.08% 251

Other funds holding INSM

Profund Advisors's INSM Position: Q2 2026 in Review

Profund Advisors reduced its Insmed (INSM) stake by 48% in Q2 2026, selling an estimated $1.61M and leaving 14,602 shares worth $1.56M. The position accounts for 0.04% of the portfolio, ranked #259.

Profund Advisors first reported a position in INSM in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.85M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Profund Advisors held 14,602 shares of Insmed worth $1.56M as of Q2 2026.
  • Profund Advisors sold 13,335 Insmed shares in Q2 2026, an estimated $1.61M.
  • Insmed made up 0.04% of Profund Advisors's portfolio in Q2 2026, its #259 holding.
  • Profund Advisors first reported a position in Insmed in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Insmed position peaked at $4.85M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.